| Issue |
Section |
Title |
File |
| Vol 4, No 4 (2002) |
Articles |
Vozmozhnosti ispol'zovaniya taksotera pri razlichnykh solidnykh opukholyakh |
|
| Vol 9, No 3 (2007) |
Articles |
Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei |
|
| Vol 10, No 3 (2008) |
Articles |
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy |
|
| Vol 15, No 2 (2013) |
Articles |
Toxicity of trabectedin-based combinations in the treatment of different malignant tumors |
|
| Vol 15, No 4 (2013) |
Articles |
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer |
|
| Vol 16, No 1 (2014) |
Articles |
Selection of the anti-angiogenesis therapy for the first-line chemotherapy in advanced ovarian cancer |
|
| Vol 17, No 3 (2015) |
Articles |
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer |
|
| Vol 18, No 1 (2016) |
Articles |
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia) |
(Rus)
|
| Vol 18, No 3 (2016) |
Articles |
Who or what does influence the optimal choice of medication administration route? Is this the solution of clinician, patient or State? New and it should seem unexpected questions for Russian Health Care |
(Rus)
|
| Vol 18, No 4 (2016) |
Articles |
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice |
(Rus)
|
| Vol 19, No 1 (2017) |
Articles |
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer |
(Rus)
|
| Vol 19, No 3 (2017) |
Articles |
Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer |
(Rus)
|
| Vol 13, No 1 (2011) |
Articles |
Izmenenie podkhoda k lecheniyu platinochuvstvitel'nykh retsidivov raka yaichnikov |
|
